Comparison of the clinical efficacy and comfort of olopatadine hydrochloride 0.1% ophthalmic solution and nedocromil sodium 2% ophthalmic solution in the human conjunctival allergen challenge model
- 1 December 2000
- journal article
- clinical trial
- Published by Elsevier in Clinical Therapeutics
- Vol. 22 (12) , 1462-1472
- https://doi.org/10.1016/s0149-2918(00)83044-1
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The role of IL-12 in the induction of late-phase cellular infiltration in a murine model of allergic conjunctivitisJournal of Allergy and Clinical Immunology, 2000
- Comparison of Topical 0.05% Levocabastine and 0.1% Lodoxamide in Patients with Allergic ConjunctivitisEuropean Journal of Ophthalmology, 1998
- Evaluation of Olopatadine, a New Ophthalmic Antiallergic Agent with Dual Activity, Using the Conjunctival Allergen Challenge ModelAnnals of Allergy, Asthma & Immunology, 1998
- Combined analysis of two studies using the conjunctival allergen challenge model to evaluate olopatadine hydrochloride, a new ophthalmic antiallergic agent with dual activityAmerican Journal of Ophthalmology, 1998
- Seasonal allergic conjunctivitis is accompanied by increased mast cell numbers in the absence of leucocyte infiltrationClinical and Experimental Allergy, 1997
- Histaminase Activity in Patients with Vernal KeratoconjunctivitisOphthalmology, 1995
- Conjunctivitis of allergic origin: Immunologic mechanisms and current approaches to therapySurvey of Ophthalmology, 1993
- Allergic Conjunctivitis: A Survey of New AntihistaminesJournal of Ocular Pharmacology and Therapeutics, 1991
- Effects of Vasocon-A in the Allergen Challenge Model of Acute Allergic ConjunctivitisArchives of Ophthalmology (1950), 1990
- Tear Histamine Levels in Vernal Conjunctivitis and Other Ocular InflammationsOphthalmology, 1980